GlassScriptPhysician profile
Luis A Lopez Galarza
NPI 1770624116
$2,913.00
in general payments reported to CMS, 2019-2025
12 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,824 · 2021: $286 · 2022: $247 · 2023: $183 · 2024: $108 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,334.72 | 2019 | |
| Medtronic, INC. | $315.21 | 2021-2025 | Endurant Iis, Hawkone |
| Lemaitre Vascular, INC. | $242.65 | 2021-2023 | Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $236.19 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Janssen Pharmaceuticals, INC | $218.83 | 2019-2023 | Xarelto |
| Johnson and Johnson International | $147.45 | 2019-2025 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Edwards Lifesciences Corporation | $134.32 | 2019-2022 | |
| Medtronic Vascular, INC. | $104.07 | 2019 | |
| Bard Peripheral Vascular, INC. | $95.50 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.03 | 2019 | |
| Inspire Medical Systems, INC. | $18.46 | 2025 | Inspire |
| Chiesi USA, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis A Lopez Galarza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.